fda approved glp-1 agonists New Pill Foundayo (Orforglipron) Gets Approval for Obesity The New Weight Management Meds
Description
In all patients, there was a 44% reduction in risk of colorectal cancer when using GLP-1RAs as compared to insulin, and a 25% reduction in risk as compared to metformin use
Bisgaard LS, Bosteen MH, Fink LN, Srensen CM, Rosendahl A, Mogensen CK, Rasmussen SE, Rolin B, Nielsen LB, Pedersen TX
Some patients might prefer or respond better to amylin analogues
It might be time for a different approach
